Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C56 - Skills Workshop: Interventional Headache Management: Botulinum Toxin, Nerve Blocks, and Trigger Point Injections

Sunday 04/14/24
01:00 PM - 05:30 PM MDT Add To Calendar
Hyatt Regency | Mineral Hall A
This program will be presented in-person only
This program is not expected to be available in the meeting's On Demand product.
Skills Workshop
Hope O'Brien, MD, FAAN, MBA
Headache
Participants should become familiar with the indications of interventional treatment of headache which include invasive and non-invasive options. Invasive techniques include peripheral cranial nerve blocks, trigger point injections, and onabotulinumtoxinA. Non-invasive treatment include the use of neurmodulation devices. Participants will gain hands-on experience with these techniques during break-out sessions.
 
This program is supported in part by an educational grant, specifically monetary and in-kind support of medical equipment and supplies, from AbbVie Inc.
4.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Introductory
Fellow, Resident, General Neurologist, Advanced Practice Provider
Case-based, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:15 PM MDT Introduction Introduction to Interventional Headache Management
Hope O'Brien, MD, FAAN, MBA
01:15 PM - 02:00 PM MDT Speaker OnabotulinumtoxinA in the Treatment of Chronic Migraine
Andrew M. Blumenfeld, MD, FAAN
02:00 PM - 02:45 PM MDT Speaker Cranial Nerve Blocks and Trigger Point Injections to Treat Head Pain
Lauren R. Natbony, MD
02:45 PM - 03:30 PM MDT Speaker The Use of Neuromodulation and the Role of Surgical Intervention in Headache Management
Michael J. Marmura, MD, FAAN
03:30 PM - 03:50 PM MDT Q&A Speaker Panel Discussion
Lauren R. Natbony, MD, Andrew M. Blumenfeld, MD, FAAN, Michael J. Marmura, MD, FAAN, Rashmi B. Halker Singh, MD, FAAN
03:50 PM - 04:00 PM MDT Break Break and Transition to Stations
04:00 PM - 05:30 PM MDT Discussion Breakout Stations
Lauren R. Natbony, MD, Andrew M. Blumenfeld, MD, FAAN, Michael J. Marmura, MD, FAAN, Rashmi B. Halker Singh, MD, FAAN
Faculty Disclosures
Hope O'Brien, MD, FAAN, MBA The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GatherED . The institution of Dr. O'Brien has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. An immediate family member of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Astra Zenica. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. O'Brien has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ms. Medicine. The institution of Dr. O'Brien has received research support from Abbvie. The institution of Dr. O'Brien has received research support from Eli Lilly. Dr. O'Brien has received publishing royalties from a publication relating to health care. Dr. O'Brien has a non-compensated relationship as a Accreditation Council Member with UCNS that is relevant to AAN interests or activities.
Lauren R. Natbony, MD Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceuticals. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNeura. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Natbony has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel Pharmaceuticals . Dr. Natbony has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Andrew M. Blumenfeld, MD, FAAN Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck.
Michael J. Marmura, MD, FAAN Dr. Marmura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Marmura has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Marmura has stock in Curelator. The institution of Dr. Marmura has received research support from Teva. The institution of Dr. Marmura has received research support from AbbVie. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care.
Rashmi B. Halker Singh, MD, FAAN Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Halker Singh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology & Neuroscience Reports. Dr. Halker Singh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache Journal. Dr. Halker Singh has received publishing royalties from a publication relating to health care. Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Pri-med. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Medscape.